Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: ADIRA (Anti-inflammatory Diet In Rheumatoid Arthritis) [NA]
The ADIRA trial evaluating an anti-inflammatory diet in rheumatoid arthritis has completed.
-
FDA approval · 2024-10-11FDA Approved: HYDROXYCHLOROQUINE SULFATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for hydroxychloroquine sulfate submitted by Aurobindo Pharma Limited.
-
FDA label_change · 2024-10-10FDA Approved: SOVUNA — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for SOVUNA (hydroxychloroquine sulfate) by ANI Pharmaceuticals, Inc., indicating a label change.
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Assessment of Interstitial Lung Disease in Rheumatoid Arthritis by Lung Ultrasound
This clinical trial update reports on evaluating interstitial lung disease in rheumatoid arthritis using lung ultrasound.
-
CLINICAL_TRIALS research · 2024-10-09Clinical Trial Update: WORK-ON Vocational Rehabilitation for People with Inflammatory Arthritis [NA]
The WORK-ON Vocational Rehabilitation trial for people with inflammatory arthritis is currently recruiting, sponsored by The Danish Center f…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: A Study to Compare Efficacy and Safety of CT-P47 and RoActemra in Patients With Rheumatoid Arthritis [Phase 3]
Phase 3 trial comparing a biosimilar CT-P47 to RoActemra (tocilizumab) in rheumatoid arthritis; results from the completed study have been p…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Rheumatoid Arthritis (RA) [Phase 2]
Phase 2 trial evaluating subcutaneous ABBV-154 in moderately to severely active rheumatoid arthritis was terminated, with results on adverse…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: A Study To Describe The Use Of Tofacitinib After Use Of Rituximab In Patients With Rheumatoid Arthritis In A Real-World Setting
A real-world observational study evaluating the use of tofacitinib after rituximab treatment in patients with rheumatoid arthritis, with res…
-
CLINICAL_TRIALS research · 2024-10-08Clinical Trial Update: Health Promotion of People With Disabilities [Phase 2, Phase 3]
Phase 2 and Phase 3 clinical trial update sponsored by the CDC on health promotion for people with disabilities, focusing on rheumatoid arth…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Efficacy Of Upadacitinib In Psoriatic Arthritis And Comparison To Rheumatoid Arthritis.
An ongoing clinical trial update evaluating the efficacy of upadacitinib in psoriatic arthritis and comparing its effects to rheumatoid arth…
-
CLINICAL_TRIALS trial_result · 2024-10-04Clinical Trial Update: 10-year Follow-up of Patients With Rheumatoid Arthritis Who Received Structured Treat-to-target Therapy in Early Disease
This document reports the 10-year outcomes of rheumatoid arthritis patients who received a structured treat-to-target strategy in the early …
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: Comparative, Multicenter Study in Subjects with Rheumatoid Arthritis, ALVOFLEX [Phase 3]
A Phase 3, multicenter comparative trial evaluating ALVOFLEX for rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: IDentification of Factors Predictive of Tofacitinib's Survival in Patient With Rheumatoid Arthritis
A Pfizer-sponsored clinical trial on tofacitinib in rheumatoid arthritis identified factors predictive of patient survival; the study has co…
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Musculoskeletal Ultrasound with Elastography in the Evaluation of Muscle State in Rheumatoid Arthritis Patients
Clinical trial assessing musculoskeletal ultrasound with elastography to evaluate muscle state in patients with rheumatoid arthritis; the st…
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: The Effect of the Ideal Food Pyramid on Rheumatoid Arthritis [NA]
A completed clinical trial evaluating the effect of the Ideal Food Pyramid on rheumatoid arthritis.
-
FDA approval · 2024-09-27FDA Approved: CELECOXIB — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Celecoxib from Actavis Pharma, Inc.
-
FDA approval · 2024-09-26FDA Approved: LEFLUNOMIDE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Leflunomide submitted by Apotex Corp. under the existing Leflunomide approval.
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: A Study of the Efficacy and Safety of TACI-antibody Fusion Protein Injection (RC18) in Subjects with Inadequate Response to MTX Due to Treat Moderate and Severe Rheumatoid Arthritis. [Phase 3]
A completed Phase 3 trial evaluating the efficacy and safety of RC18, a TACI-antibody fusion protein, in patients with moderate to severe rh…
-
FDA approval · 2024-09-26FDA Approved: LEFLUNOMIDE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Leflunomide submitted by Zydus Lifesciences Limited.
-
FDA approval · 2024-09-26FDA Approved: LEFLUNOMIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application from Aurobindo Pharma Limited for Leflunomide (generic).
-
CLINICAL_TRIALS research · 2024-09-26Clinical Trial Update: Assessment of Serum CD25 Level in Systemic Sclerosis Patients with or Without Interstitial Lung Disease (ILD)
A not-yet-recruiting clinical trial sponsored by Assiut University to measure serum SCD25 levels in rheumatoid arthritis, systemic sclerosis…
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: The ArthritisPower Wearable Study
This entry notes the completion of the ArthritisPower Wearable Study in rheumatoid arthritis. No results are provided in the snippet.
-
FDA approval · 2024-09-23FDA Approved: LEFLUNOMIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for Leflunomide from Alembic Pharmaceuticals Limited, confirming continued approval of the generic p…
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: Efficacy of Chinese Herbal Medicine Qing Re Huo Xue in Patients With Rheumatoid Arthritis [Phase 2, Phase 3]
ClinicalTrials.gov reports on the efficacy evaluation of Qing Re Huo Xue, a Chinese herbal medicine, for rheumatoid arthritis in Phase 2 and…
-
CLINICAL_TRIALS research · 2024-09-20Clinical Trial Update: Study of the Causal Link Between Rheumatoid Arthritis and Periodontitis Using Mendelian Randomization
This study investigates whether rheumatoid arthritis and periodontitis have a causal relationship using Mendelian randomization, and is curr…